Molecular aspects in clinical hemostasis research at Karolinska Institutet.
The development of hemostasis research at Karolinska Institutet is described, focusing first on the initial findings of the fibrinogen structure and the hereditary bleeding disorders, hemophilia A and von Willebrand's disease. Basic research has focused on new biomarkers for cardiovascular/thromboembolic disorders, such as myocardial infarction and stroke, including preeclampsia and diabetes, with studies on the importance of decreased fibrinolysis in these disorders. Since long, the structure of the fibrin network has been evaluated, and recently the influence of aspirin and new thrombin and factor Xa inhibitors has been investigated. Research on the contact pathway of coagulation has also started at the Unit.
Blombäck
Margareta
M
Coagulation Research Unit, Department of Molecular Medicine and Surgery, Karolinska Institutet, SE-17176 Stockholm, Sweden. Margareta.Blomback@ki.se
D000047:Academies and Institutes; D000925:Anticoagulants / Q000494:pharmacology; D035843:Biomedical Research / Q000639:trends; D001779:Blood Coagulation Factors / Q000235:genetics / Q000378:metabolism; D005342:Fibrinolysis; D006487:Hemostasis; D006493:Heparin / Q000378:metabolism; D006801:Humans; D009203:Myocardial Infarction / Q000097:blood / Q000378:metabolism; D020521:Stroke / Q000097:blood / Q000378:metabolism; D013548:Sweden; D014842:von Willebrand Diseases / Q000235:genetics / Q000378:metabolism
D000925:Anticoagulants; D001779:Blood Coagulation Factors; D006493:Heparin